RBOT director Joseph Doherty receives 8,003-share option at $7.61

Rhea-AI Filing Summary

Vicarious Surgical Inc. (RBOT) director Joseph Edward Doherty was granted a stock option on 06/27/2025 to buy 8,003 shares of Class A common stock at an exercise price of $7.61 per share. After the grant, the reporting person beneficially owns 8,003 shares tied to this option on a direct basis.

The option's underlying shares will vest on 06/27/2026 or one day prior to the issuer's next annual meeting of shareholders, whichever is earlier, subject to the reporting person's continued service. The Form 4 was signed by an attorney-in-fact on 10/02/2025.

Positive

• 8,003-share option granted to a director, aligning interests with shareholders
• Option grant has a clear vesting date of 06/27/2026, promoting retention

Negative

• Vesting is contingent on continued service, so the shares are not immediately available
• Exercise price of $7.61 requires cash outlay to convert options into shares

Insights

Corporate Governance Analyst

Director received an equity grant aligning interests with shareholders.

The option granted on 06/27/2025 covers 8,003 shares with a $7.61 exercise price and is held directly by the reporting person. Equity awards to directors are typical compensation mechanisms to align long-term interests.

The grant vests on 06/27/2026 or one day before the next annual meeting, contingent on continued service, which ties the award to retention through the next year.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Doherty Joseph Edward

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (right to buy)	8,003	$0.00	$0.00

Holdings After Transaction: Stock Option (right to buy) — 8,003 shares (Direct)

Footnotes (1)

1. F1. All of the shares underlying this option will vest on June 27, 2026, or one day prior to the Issuer's next Annual Meeting of Shareholders, whichever is earlier, subject to the Reporting Person's continued service through the applicable vesting date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 10/02/2025 - 04:20 PM Learn about SEC filing dates

FAQ

What did Vicarious Surgical (RBOT) disclose in this Form 4?

The Form 4 reports that director Joseph Edward Doherty was granted a stock option on 06/27/2025 to buy 8,003 Class A shares at an exercise price of $7.61.

When do the option shares vest for RBOT director Joseph Doherty?

The shares underlying the option vest on 06/27/2026 or one day prior to the issuer's next annual meeting of shareholders, whichever is earlier, subject to continued service.

How many shares does the reporting person beneficially own after the transaction?

Following the reported transaction the reporting person beneficially owns 8,003 shares related to this option on a direct basis.

What is the exercise price and expiration detail reported?

The reported exercise price is $7.61. The Form 4 shows an entry with a date of 06/26/2035 in the date-exercisable/expiration area.

Who signed the Form 4 and when was it signed?

The Form 4 was signed by Sarah Romano, Attorney-in-Fact on 10/02/2025.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Doherty Joseph Edward

(Last) (First) (Middle)

C/O VICARIOUS SURGICAL INC.

78 FOURTH AVENUE

(Street)

WALTHAM MA 02451

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Vicarious Surgical Inc. [ RBOT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
06/27/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$7.61	06/27/2025		A		8,003		(1)	06/26/2035	Class A Common Stock	8,003	$0.00	8,003	D

Explanation of Responses:

1. All of the shares underlying this option will vest on June 27, 2026, or one day prior to the Issuer's next Annual Meeting of Shareholders, whichever is earlier, subject to the Reporting Person's continued service through the applicable vesting date.

	/s/ Sarah Romano, Attorney-in-Fact	10/02/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.